Question 1

Does Wolverine Asset Management own SAREPTA THERAPEUTICS stock?

Accepted Answer

No. Wolverine Asset Management exited its SAREPTA THERAPEUTICS position in Q3 2025. Its Q2 2025 13F listed 9,940,000 shares worth $7.3M.

Question 2

How many shares of SAREPTA THERAPEUTICS does Wolverine Asset Management own?

Accepted Answer

None since Q3 2025, when Wolverine Asset Management exited the position. Its Q2 2025 13F listed 9,940,000 shares worth $7.3M.

Question 3

What is Wolverine Asset Management's SAREPTA THERAPEUTICS position worth?

Accepted Answer

Wolverine Asset Management's SAREPTA THERAPEUTICS position was worth $7.3M in its Q2 2025 13F, before the exit in Q3 2025.

Question 4

Is Wolverine Asset Management buying or selling SAREPTA THERAPEUTICS?

Accepted Answer

In Q3 2025, Wolverine Asset Management exited its entire SAREPTA THERAPEUTICS position.

Question 5

When did Wolverine Asset Management first buy SAREPTA THERAPEUTICS?

Accepted Answer

Wolverine Asset Management already held SAREPTA THERAPEUTICS in its Q3 2023 13F, the earliest on record, and listed it in 6 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2025-Q2	Decreased	9.9M	-75.4%	$7.3M	0.1%	—	0
2025-Q1	New	40.4M	—	$37.7M	0.5%	—	48
2024-Q3	Exited	0	-100.0%	$0	0.0%	—	0

SASAREPTA THERAPEUTICS INC